Rockefeller Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
Other funds holding BDSI
Rockefeller Capital Management's BDSI Position: Q1 2022 in Review
Rockefeller Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 68 shares.
Rockefeller Capital Management first reported a position in BDSI in Q3 2021 and held it in 2 quarters. The position peaked at $0 in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Rockefeller Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Rockefeller Capital Management sold 68 BioDelivery Sciences International, Inc. shares in Q1 2022.
- Rockefeller Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2021 and held it in 2 quarters.
- Rockefeller Capital Management's BioDelivery Sciences International, Inc. position peaked at $0 in Q4 2021.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Rockefeller Capital Management's 13F filing for Q1 2022, filed 13 May 2022.